284 related articles for article (PubMed ID: 21492414)
1. The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide.
Ramberg V; Tracy LM; Samuelsson M; Nilsson LN; Iverfeldt K
J Neuroinflammation; 2011 Apr; 8():34. PubMed ID: 21492414
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer amyloid-beta peptides block the activation of C/EBPbeta and C/EBPdelta in glial cells.
Samuelsson M; Ramberg V; Iverfeldt K
Biochem Biophys Res Commun; 2008 Jun; 370(4):619-22. PubMed ID: 18405661
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes.
Kanamori Y; Murakami M; Sugiyama M; Hashimoto O; Matsui T; Funaba M
J Biol Chem; 2017 Jun; 292(24):10275-10287. PubMed ID: 28438835
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein delta (C/EBPdelta) expression and elevation in Alzheimer's disease.
Li R; Strohmeyer R; Liang Z; Lue LF; Rogers J
Neurobiol Aging; 2004 Sep; 25(8):991-9. PubMed ID: 15212823
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells.
Kolyada AY; Madias NE
Mol Med; 2001 May; 7(5):329-43. PubMed ID: 11474579
[TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer binding protein delta in microglial activation.
Ejarque-Ortiz A; Gresa-Arribas N; Straccia M; Mancera P; Solà C; Tusell JM; Serratosa J; Saura J
J Neurosci Res; 2010 Apr; 88(5):1113-23. PubMed ID: 19908286
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.
Valente T; Dentesano G; Ezquerra M; Fernandez-Santiago R; Martinez-Martin J; Gallastegui E; Domuro C; Compta Y; Martí MJ; Bachs O; Márquez-Kisinousky L; Straccia M; Solà C; Saura J
Cell Death Differ; 2020 Feb; 27(2):509-524. PubMed ID: 31209363
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway.
Yang R; Liu S; Zhou J; Bu S; Zhang J
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):276-284. PubMed ID: 28669260
[TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer binding protein δ regulates glial proinflammatory gene expression.
Valente T; Straccia M; Gresa-Arribas N; Dentesano G; Tusell JM; Serratosa J; Mancera P; Solà C; Saura J
Neurobiol Aging; 2013 Sep; 34(9):2110-24. PubMed ID: 23523267
[TBL] [Abstract][Full Text] [Related]
10. Requirement for nuclear factor kappa B signalling in the interleukin-1-induced expression of the CCAAT/enhancer binding protein-delta gene in hepatocytes.
Ali S; Singh NN; Yildirim H; Ramji DP
Int J Biochem Cell Biol; 2010 Jan; 42(1):113-9. PubMed ID: 19800021
[TBL] [Abstract][Full Text] [Related]
11. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
12. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.
Karlsen JR; Borregaard N; Cowland JB
J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144
[TBL] [Abstract][Full Text] [Related]
13. Gx-50 reduces β-amyloid-induced TNF-α, IL-1β, NO, and PGE2 expression and inhibits NF-κB signaling in a mouse model of Alzheimer's disease.
Shi S; Liang D; Chen Y; Xie Y; Wang Y; Wang L; Wang Z; Qiao Z
Eur J Immunol; 2016 Mar; 46(3):665-76. PubMed ID: 26643273
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent response of CCAAT/enhancer binding proteins following traumatic brain injury in mice.
Sandhir R; Berman NE
Neurochem Int; 2010 Jan; 56(1):188-93. PubMed ID: 19833158
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells.
Lee YJ; Choi DY; Choi IS; Han JY; Jeong HS; Han SB; Oh KW; Hong JT
J Neuroinflammation; 2011 Oct; 8():132. PubMed ID: 21982455
[TBL] [Abstract][Full Text] [Related]
16. Bis(ethylmaltolato)oxidovanadium (IV) attenuates amyloid-beta-mediated neuroinflammation by inhibiting NF-κB signaling pathway via a PPARγ-dependent mechanism.
He Z; Li X; Han S; Ren B; Hu X; Li N; Du X; Ni J; Yang X; Liu Q
Metallomics; 2021 Jul; 13(7):. PubMed ID: 34124763
[TBL] [Abstract][Full Text] [Related]
17. IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPdelta.
Dong J; Fujii S; Imagawa S; Matsumoto S; Matsushita M; Todo S; Tsutsui H; Sobel BE
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C209-15. PubMed ID: 16914534
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
19. The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.
Zhao J; O'Connor T; Vassar R
J Neuroinflammation; 2011 Nov; 8():150. PubMed ID: 22047170
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
